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White spot syndrome virus (WSSV) is a large DNA virus infecting shrimp and other crustaceans. The virus particles contain
at least five major virion proteins, of which three (VP26, VP24, and VP15) are present in the rod-shaped nucleocapsid and two
(VP28 and VP19) reside in the envelope. The mode of entry and systemic infection of WSSV in the black tiger shrimp, Penaeus
monodon, and the role of these proteins in these processes are not known. A specific polyclonal antibody was generated
against the major envelope protein VP28 using a baculovirus expression vector system. The VP28 antiserum was able to
neutralize WSSV infection of P. monodon in a concentration-dependent manner upon intramuscular injection. This result
suggests that VP28 is located on the surface of the virus particle and is likely to play a key role in the initial steps of the
systemic WSSV infection in shrimp. © 2001 Academic Press
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INTRODUCTION
White spot syndrome virus (WSSV) is a major disease
agent of penaeid shrimp in Southeast Asia, the Indian
continent, and in South and Central America (Rosenberg,
2000). The disease is caused by an ovoid-to-bacilliform
virus with a rod-shaped nucleocapsid and a tail-like
appendix at one end of the virion (Durand et al., 1997;
Nadala et al., 1998). The virus contains a double-
stranded DNA with an estimated size of 290 kbp (Yang et
al., 1997). Genetic analysis indicates that WSSV is a
representative of a new virus group provisionally named
whispovirus (Van Hulten et al., 2000b; Tsai et al., 2000).
WSSV has a broad host range, infecting several crus-
tacean species, like shrimp, crab, and crayfish (Wang et
al., 1998). Little is known about WSSV infection and
morphogenesis in vivo. Upon infection per os, infected
cells are observed first in the stomach, gill, and cuticular
epidermis of the shrimp. The infection subsequently
spreads systemically in the shrimp to other tissues of
mesodermal and ectodermal origin (Chang et al., 1996).
Research on virus replication and virion morphogenesis
shows that DNA replication and de novo envelope for-
mation take place in the nucleus (Durand et al., 1997;
Wang et al., 2000). The mechanism of virus entry into the
shrimp and of the spread of the virus in the crustacean
body is not known.
The virus particle consists of at least five major pro-
teins with estimated sizes of 28 kDa (VP28), 26 kDa
(VP26), 24 kDa (VP24), 19 kDa (VP19), and 15 kDa (VP15).
VP28 and VP19 are associated with the virion envelope
and VP26, VP24, and VP15 with the nucleocapsid (Van
Hulten et al., 2000c). Amino acid analysis of VP28, VP26
and VP24 indicated that these proteins have about 40%
amino acid identity and that their genes may have
evolved from a common ancestral gene (Van Hulten et
al., 2000a). The role of the envelope and its proteins in
the establishment of the systemic infection process has
not been determined.
Neutralization experiments have often been performed
to study the role of virion proteins or their domains in the
infection process. Neutralizing antibodies bind to enve-
lope spikes on the virion and prevent attachment of the
virus to the cell surface, cell entry, or virus uncoating
(Burton et al., 2000). For many vertebrate viruses like
poxviruses (Galmiche et al., 1999) and hepadnaviruses
(Sunyach et al., 1999) in vitro neutralization experiments
involving cell cultures (plaque reduction assays) have
been used for this purpose. For invertebrate baculovi-
ruses, in vitro neutralization experiments have been ex-
ploited to show that Autographa californica nucleopoly-
hedrovirus (AcMNPV) can be neutralized by complexing
the budded virions with specific antibodies against the
viral envelope protein (GP64) (Volkman and Goldsmith,
1985). These authors showed that the mechanism of
neutralization is by inhibition of virus entry and adsorp-
tive endocytosis. However, standardized (primary)
shrimp cell cultures are not available and therefore an in
vivo approach is followed.
In vivo neutralization experiments have been widely
used for many vertebrate viruses and have even led to
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228passive immunization strategies. When combined with
the use of monoclonal antibodies, this strategy has been
used to identify the virion protein epitope(s) involved in
the neutralization (e.g., Schofield et al., 2000). In vivo
neutralization assays have also been successfully used
in insects, e.g., in inhibiting infection of larvae of the
Douglas fir tussock moth Orgyia pseudotsugata with its
nucleopolyhedrovirus (OpMNPV) using OpMNPV anti-
serum (Martignoni et al., 1980). This strategy has now
been applied to shrimp with the added advantage that it
is as close as possible to the in vivo situation. In this
paper we provide evidence that VP28 is directly involved
in the systemic infection of the shrimp P. monodon by
WSSV.
RESULTS
Virus titration
A WSSV virus stock was produced in the crayfish P.
clarkii by intramuscular injection of purified WSSV. To
determine the dilution resulting in 90±100% mortality in
the black tiger shrimp P. monodon, an in vivo virus titra-
tion was performed using animals of approximately1gi n
weight. The virus stock was diluted in steps from 1 3 10
5
to 5 3 10
11 times in 330 mM NaCl as indicated (Fig. 1)
and for each dilution 10 ml was injected intramuscularly
into 10 shrimp. Shrimp that were injected with 330 mM
NaCl served as negative control for the infection. All
shrimp serving as negative control (not shown) and
those having received the 5 3 10
11 virus dilution sur-
vived, whereas mortality due to virus infection occurred
in all groups with a lower virus dilution (Fig. 1). Admin-
istration of virus dilutions of 1 3 10
5 and 1 3 10
7 resulted
in almost 100% mortality in a period of 20 days. A delay
in mortality was observed when virus dilutions of 1 3 10
8
and 5 3 10
9 were used. The 1 3 10
8 dilution resulted in
90% final mortality, but the time of mortality was delayed
and spanned a period of 40 days. The experiment was
repeated with the 1 3 10
7, the 1 3 10
8, and the 5 3 10
9
dilution yielding essentially the same results. The dilu-
tion of 1 3 10
8 was chosen as the virus dose for further
experiments as this condition was expected to give the
optimal response to the neutralization in terms of mor-
tality reduction.
Antibody against recombinant VP28
The major WSSV envelope protein VP28 was ex-
pressed under control of the polyhedrin promoter in
insect cells using recombinant baculovirus AcMNPV-
WSSVvp28 (Van Hulten et al., 2000c) and was used after
purification to raise specific polyclonal antibodies in rab-
bits. The VP28 polyclonal antiserum reacted strongly
with baculovirus expressed as well as with bacterial
expressed VP28 (data not shown).
As VP28 shows a considerable degree of amino acid
homology with nucleocapsid proteins VP26 and VP24
(Van Hulten et al., 2000a), the specificity of the polyclonal
was tested against purified WSSV virions and WSSV
nucleocapsids (Fig. 2). All major proteins are present in
the virion fraction (Fig. 2A, lane 2) and only VP26, VP24
and VP15 are present in the nucleocapsid fraction (Fig.
FIG. 1. Titration of WSSV in P. monodon shrimp. Days postinjection of the virus are shown on the abscissa and the accumulated mortality (in %)
on the ordinate. Ten microliters of a 1 3 10
5,13 10
7,13 10
8,53 10
9,o r53 10
11 diluted virus stock was injected.
229 NEUTRALIZATION OF WSSV INFECTION IN SHRIMP2A, lane 3). In the Western analysis (Fig. 2B) the VP28
antiserum (1:5000 dilution) shows a clear reaction with
the VP28 present in the WSSV virion (Fig. 2B, lane 2). A
minor reaction was observed with smaller products,
most likely VP28 breakdown products. There was no
reaction with proteins of the WSSV nucleocapsids (Fig.
2B, lane 3). This shows that there is no cross-reactivity of
the VP28 polyclonal antiserum with VP26 or VP24, de-
spite the notable degree of amino acid homology.
WSSV neutralization in vivo
The VP28 polyclonal antiserum was used in an in vivo
neutralization assay in P. monodon. A constant amount of
WSSV was incubated with various antiserum concentra-
tions (Table 1) and injected into shrimp. No shrimp died
in the negative control injected only with 330 mM NaCl
(group 6). The shrimp in the positive control, which were
injected with WSSV only (group 1), showed a 100% mor-
tality at day 23 (Fig. 3). Addition of the preimmune serum
(group 2) resulted in a small initial delay in shrimp mor-
tality, which reached 100% at day 25 (Fig. 3). When the
virus was preincubated with a 10-fold dilution of the VP28
antiserum (group 3), shrimp mortality was 100% at day
22. Apparently the VP28 antiserum at this dilution is not
able to neutralize the virus. When the VP28 serum is
diluted only two times (group 4) or used undiluted (group
5), none of the shrimp died, indicating that WSSV can be
FIG. 2. (A) Fifteen percent Coomassie brilliant blue-stained SDS±PAGE gel of purified WSSV. Lane 1, low-molecular-weight protein marker. Lane 2,
purified WSSV virions. Lane 3, purified WSSV nucleocapsids. (B) Western blot of the virions (lane 2) and nucleocapsid (lane 3) of A. VP28 polyclonal
antiserum is used and detection is performed with the ECL kit.
TABLE 1
Constitution of Injection Solutions
Group
No. Type
Injection
(10 ml total)
No.
shrimp
1 Positive control WSSV 10
2 Preimmune serum
control
WSSV 1 9 ml preimmune
serum
15
31 0 3 dilution of VP28
antiserum
WSSV 1 1 ml VP28
antiserum
15
42 3 dilution of VP28
antiserum
WSSV 1 5 ml VP28
antiserum
15
5 VP28 antiserum WSSV 1 9 ml VP28
antiserum
15
6 Negative control 330 mM NaCl 10
Note. The first column shows the group numbers, the second the
treatment, the third the content of the 10-ml injected volume, and the
fourth the number of shrimp used in each group. The total amount of
WSSV injected is the same for groups 1 to 5.
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manner (Fig. 3).
DISCUSSION
To study the role of the major WSSV envelope protein
VP28 in WSSV infection, a specific antiserum was pro-
duced against this protein. As there is a significant de-
gree of homology between the envelope protein VP28
and the nucleocapsid proteins VP26 (41% amino acid
similarity) and VP24 (46% amino acid similarity) (Van
Hulten et al., 2000a), a Western analysis (Fig. 2) was
performed, confirming the specificity of the VP28 poly-
clonal antiserum for VP28.
A WSSV virus stock was produced from infected P.
clarkii. Since an absolute measure of virus activity in
infectious units cannot be given, we have determined the
highest virus dilution of the virus stock that results in
almost 100% mortality upon injection of a fixed volume
(10 ml) into shrimp. Shrimp were used for the titration of
the virus stock, as no reliable cell culture system is
available to measure WSSV infection and the effect of
neutralization. Since the 1 3 10
8 dilution of the virus
stock was the lowest dose still resulting in almost 100%
final mortality (Fig. 1), this dilution was used for neutral-
ization experiments. In the latter experiments (Fig. 3) the
dilution of 1 3 10
8 resulted in a somewhat quicker
mortality (Fig. 3, group 1: WSSV) than in the titration
experiment (Fig. 1). This difference in response might be
the consequence of the use of a different batch of
shrimp. However, this does not influence the results of
the neutralization experiment, as a control (no antiserum)
was included.
To study the role of VP28 in WSSV infection in shrimp,
an in vivo neutralization test was performed. This test
showed that WSSV infection was neutralized by the VP28
polyclonal antiserum (Fig. 3) and that VP28 is involved in
this process. The preimmune serum control resulted in a
small delay of shrimp mortality. This could be due to
compounds present in the serum stimulating the shrimp
defense system. WSSV neutralization using the VP28
polyclonal antiserum was concentration dependent; only
the two highest antibody concentrations used in this
study resulted in neutralization (Fig. 3).
VP28 is the major protein in the WSSV envelope, but its
location in this structure is not known. The neutralizing
activity of the VP28 antiserum shown here might depend
on the relative abundance of this protein on the virion
envelope. However, mere binding of the antibody to the
surface of the virus does not automatically result in virus
neutralization. The existence of nonneutralizing antibod-
ies, which bind to virus without diminishing infectivity,
has long been recognized (Dimmock, 1984). In other
virus systems only anti-envelope antibodies binding to
the envelope spike on the virion will be neutralizing or
show antiviral activity (Burton et al., 2000). Therefore, we
postulate that VP28 or its neutralization domain is lo-
cated in the envelope spike of WSSV virions.
Further research is required to reveal the exact role of
VP28 in WSSV infection. Neutralization of viral infectivity
by antibodies is a complex and, as yet, poorly under-
FIG. 3. Neutralization of WSSV infection in P. monodon using VP28 polyclonal antiserum. Days postinjection are shown on the abscissa and
percentage mortality on the ordinate. Treatments of the five groups used are described in Table 1.
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proteins suggest that neutralization sites and virus at-
tachment sites are often distinct (Ramsey et al., 1998).
Neutralizing antibodies often inhibit a subsequent stage
of infection, which is then responsible for the loss of
infectivity. There are only a few examples of residues
within neutralization epitopes that are also involved in
the attachment of the virus to its cellular receptor (Sun-
yach et al., 1999). For VP28 a similar situation could exist
as for the major envelope protein of the budded viruses
of AcMNPV, where the virus can be neutralized using
antibodies to GP64 (Volkman et al., 1984). Further studies
with AcMNPV showed that the mechanism of neutraliza-
tion is not by inhibition of adsorption, but by inhibition of
the fusion of the viral envelope with the cell membrane
(Volkman and Goldsmith, 1985). However, alternative
mechanisms of neutralization are possible. Inhibition can
also take place during uncoating of virus or transport of
DNA in the nucleus. Furthermore, binding of antibodies
can induce conformational changes in virus proteins and
these may be relevant for the neutralization process.
The in vivo neutralization experiments on WSSV in P.
monodon with VP28 antibodies suggest that VP28 is
located in the ªspikesº of the WSSV envelope and this
protein may thus be involved in the systemic infection of
WSSV in shrimp. It cannot be excluded that other WSSV
envelope proteins, such as VP19, are also involved in this
process, either alone or in concert with VP28. Antibodies
against VP19 will assist in the elucidation of this point.
Future experiments using in vivo neutralization will dem-
onstrate which part of VP28 is involved in the neutraliza-
tion process and what the role of VP28 in WSSV attach-
ment and entry in the systemic infection is.
MATERIALS AND METHODS
Shrimp culture
Cultures of healthy shrimp were performed in a recir-
culation system at the Laboratory of Fish Culture and
Fisheries at Wageningen University. For the experiments
shrimp were transferred to an experimental system lo-
cated at the Laboratory of Virology, Wageningen Univer-
sity, and kept in groups of 10±15 individuals in 60-liter
aquariums with an individual filter (Eheim, Germany) and
heating (Schego, Germany) at 28°C. P. monodon shrimp
of approximately 1 g were used in the titration and
neutralization experiments.
White spot syndrome virus stock production
The virus isolate used in this study originates from
infected P. monodon shrimp imported from Thailand in
1996 and was obtained as described before (Van Hulten
et al., 2000b). Crayfish Procambarus clarkii were injected
intramuscularly with a lethal dose of WSSV using a
26-gauge needle. After one week the hemolymph was
withdrawn from moribund crayfish and mixed with mod-
ified Alsever solution (Rodriguez et al., 1995) as an anti-
coagulant. The virus was purified by centrifugation at
80,000g for 1.5 h at 4°C on a 20±45% continuous sucrose
gradient in TN (20 mM Tris, 400 mM NaCl, pH 7.4). The
visible virus bands were removed and the virus particles
were subsequently sedimented by centrifugation at
45,000g at 4°C for 1 h. The virus pellet was resuspended
in TE (pH 7.5) and the virus integrity was checked by
electron microscopy. The virus stock was stored at
280°C until use in the experiments.
VP28 polyclonal antibody
The major WSSV structural envelope protein VP28 was
expressed in insect cells using baculovirus AcMNPV-
WSSVvp28 (Van Hulten et al., 2000c). The protein band
containing the VP28 was purified using a Model 491
PrepCell (Bio-Rad) according to the instruction manual.
Fractions were collected using a Model 2110 fraction
collector (Bio-Rad) and analyzed in a silver-stained SDS±
PAGE gel. Western blotting using a polyclonal WSSV
antibody was employed to determine the VP28-contain-
ing fractions. These fractions were pooled and SDS was
removed by dialysis against several volumes of 0.13 TE.
The protein was subsequently concentrated by freeze-
drying and resuspended in 0.13 TE (pH 7.5). The purified
VP28 protein (100 mg) was injected into a rabbit to pro-
duce a polyclonal antibody. The rabbit was boosted with
300 mg of VP28 after 6 weeks and the antiserum was
prepared 2 weeks thereafter.
In vivo injection
P. monodon shrimp of approximately 1 g were injected
intramuscularly with 10 ml of virus solution in 330 mM
NaCl in the fourth or fifth tail segment of the shrimp with
a 29-gauge needle (Microfine B & D). The shrimp were
subsequently cultured for a period of 40 days and the
mortality was monitored twice daily. For each group
10±15 shrimp were used. Deceased shrimp were moni-
tored for WSSV infection by viewing hemolymph extracts
under the electron microscope.
Neutralization assay
Shrimp of 1 g were injected with WSSV in the presence
or absence of VP28 antibody. A negative (330 mM NaCl)
and a positive control (virus only) were included (Table
1). The total amount of virus administered per shrimp is
constant in all groups and is equivalent to 10 mlo ft h e
1 3 10
8 dilution of the virus stock. The preimmune serum
was included as a control for the effect of the serum on
shrimp mortality. Several dilutions of the antiserum were
incubated with the virus for 1 h at room temperature,
prior to injection in shrimp. After injection, the shrimp
were monitored for 28 days and dead shrimp were ex-
232 VAN HULTEN ET AL.amined for the presence of WSSV by electron micros-
copy.
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